Abstract
Cefiderocol (FDC) is a siderophore cephalosporin with a broad spectrum of activity against many multidrug-resistant Gram-negative bacteria. Acquired resistance to FDC has been already reported among Gram-negative isolates, thus highlighting the need for rapid and accurate identification of such resistant pathogens, in order to control their spread.
Funding Information
  • I-SITE ULNE (R-TALENTS-20-004)
  • Swiss National Science Foundation (FNS 310030_1888801)

This publication has 30 references indexed in Scilit: